Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02521051
Title Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST